CTNNB1 and alopecia areata: BMD-1141 acts as a hair cycle stimulator, working through beta-catenin stimulation in cells located in type I collagen-rich tissues that express a PTH/PTHrP receptor, a different mechanism of action than the current immune suppressant treatments for alopecia areata.